SCHEMBL2713076

SCHEMBL2713076

NC(=O)c1cnc(Nc2ccc(OCCN3CCCC3)cc2)cc1N(c1ccccc1)C1CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 5/20 0.43
▸ HRH3 Q9Y5N1 4/20 0.42
▸ LTA4H P09960 4/20 0.42
▸ HRH2 P25021 1/20 0.42
▸ CHEK1 O14757 1/20 0.42
▸ JAK2 O60674 3/20 0.41
▸ IRAK4 Q9NWZ3 2/20 0.41
▸ JAK1 P23458 1/20 0.41
▸ TYK2 P29597 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ FGFR3 P22607 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ PTK2 Q05397 1/20 0.41
▸ SRC P12931 1/20 0.41
▸ EGFR P00533 1/20 0.40
▸ INSR P06213 1/20 0.40
▸ IGF1R P08069 1/20 0.40
▸ MET P08581 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ KDR P35968 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2715238 0.92 FAAH (0.42) JAK3LTA4HJAK2IRAK4JAK1
SCHEMBL2712356 0.82 JAK3 (0.46) JAK3JAK2IRAK4JAK1TYK2
SCHEMBL2713052 0.81 MAPT (0.48) HTTPTK2EGFR
SCHEMBL2695903 0.81 JAK3 (0.67) JAK3HRH3LTA4HJAK2IRAK4
SCHEMBL2694825 0.80 JAK3 (0.66) JAK3HRH3LTA4HJAK2IRAK4
SCHEMBL2715553 0.79 SYK (0.49) JAK3JAK2IRAK4JAK1TYK2
SCHEMBL2713612 0.78 MAPK10 (0.55) —
SCHEMBL2695388 0.77 HRH3 (0.48) JAK3HRH3LTA4HHRH2CHEK1
SCHEMBL2714357 0.77 SYK (0.54) JAK3JAK2IRAK4JAK1TYK2
SCHEMBL2713978 0.76 SYK (0.54) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2635557-A2 NICOTINAMIDES AS JAK KINASE MODULATORS Portola Pharmaceuticals, Inc. (US) 2013-09-11 — — EP disclosed
WO-2012061428-A2 NICOTINAMIDES AS JAK KINASE MODULATORS PORTOLA PHARMACEUTICALS, INC. (US) 2012-05-10 — — WO disclosed
Send feedback